Key result
Transplantation of iPSC cardiac spheroids with gelatin hydrogel improves LVEF in heart failure models.
Answers are grounded in this paper and cite their sources.
The severe shortage of donor hearts hampered the cardiac transplantation to patients with advanced heart failure. Therefore, cardiac regenerative therapies are eagerly awaited as a substitution. Human induced pluripotent stem cells (hiPSCs) are realistic cell source for regenerative cardiomyocytes. The hiPSC-derived cardiomyocytes are highly expected to help the recovery of heart. Avoidance of teratoma formation and large-scale culture of cardiomyocytes are definitely necessary for clinical setting. The combination of pure cardiac spheroids and gelatin hydrogel succeeded to recover reduced ejection fraction. The feasible transplantation strategy including transplantation device for regenerative cardiomyocytes are established in this study.
No takes yet. Share an insight, caveat, or question.
Kawaguchi et al. (2021) studied Heart failure (animal model). Intramyocardial transplantation of human iPS cell–derived cardiac spheroids and gelatin hydrogel was evaluated on Ejection fraction recovery. Intramyocardial transplantation of pure human iPS cell-derived cardiac spheroids combined with gelatin hydrogel successfully recovered reduced ejection fraction in heart failure animals.
Synapse has enriched 10 related papers. Consider them for comparative context: